Consolidated Statements of Operations and Comprehensive Loss (Parenthetical) - USD ($) $ in Thousands		12 Months Ended
		Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2022
Revenue		$ 446,551	$ 447,605	$ 429,909
Total cost of revenue	[1]	303,630	293,645	269,954
Research and development	[2]	49,732	57,129	57,752
Products
Revenue	[3]	234,164	233,192	214,715
Total cost of revenue		161,061	153,627	127,287
Services
Revenue	[4]	212,387	214,413	215,194
Total cost of revenue		142,569	140,018	142,667
Revenue from Joint Venture
Total cost of revenue		59,853	37,772	35,237
Research and development		942	1,463	2,336
Revenue from Joint Venture | Products
Revenue		77,497	55,658	45,545
Revenue from Joint Venture | Services
Revenue		$ 15,039	$ 10,919	$ 10,332

[1] Includes cost of revenue from sales to the joint venture, an equity method investment, of $59,853 during the year ended June 30, 2024, $37,772 during the year ended June 30, 2023, and $35,237 during the year ended June 30, 2022, respectively. See Note 11.

[2] Includes charge backs to the joint venture, an equity method investment, related to research and development of $942 during the year ended June 30, 2024, $1,463 during the year ended June 30, 2023, and $2,336 during the year ended June 30, 2022, respectively.

[3] Includes sales of products to the joint venture, an equity method investment, of $77,497 during the year ended June 30, 2024, $55,658 during the year ended June 30, 2023, and $45,545 during the year ended June 30, 2022, respectively. See Note 11.

[4] Includes sales of services to the joint venture, an equity method investment, of $15,039 during the year ended June 30, 2024, $10,919 during the year ended June 30, 2023, and $10,332 during the year ended June 30, 2022, respectively. See Note 11.